CD5 and diffuse large B-cell lymphoma: The CD5 positive rate in DLBCL is low, accounting approximately to 10% of DLBCL, and this subtype of CD5‐positive DLBCL is characterized by aggressive clinical behavior and a higher rate of CNS relapse.37, 38